Cancer Immunotherapy in Urology, An Issue of Urologic Clinics
Seiten
2020
Elsevier - Health Sciences Division (Verlag)
978-0-323-75498-9 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-75498-9 (ISBN)
The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on the following topics: Era of personalized vaccines for GU cancers; TCR and dendritic vaccine platforms for GU cancers; Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing in Cancer: Role of tumor microenvironment and immune-suppressive pathways in localized and aggressive disease; Clinical integration of neo-adjuvant platforms for prostate cancer immunotherapy; Immunotherapy for muscle and non-muscle invasive bladder cancer: BCG and beyond; Immunotherapy for metastatic bladder cancer; Immunotherapy options for metastatic castrate-resistant prostate cancer; Role of tissue infiltrating lymphocytes: Understanding TCR; Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in prostate cancer: Underlying causes and influence on response to immunotherapy; and Racial disparity in response to immunotherapy. Urologists will come away with the most current information they need to improve outcomes in the urologic cancer patient.
| Erscheinungsdatum | 26.10.2020 |
|---|---|
| Reihe/Serie | The Clinics: Surgery |
| Verlagsort | Philadelphia |
| Sprache | englisch |
| Gewicht | 450 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie |
| ISBN-10 | 0-323-75498-8 / 0323754988 |
| ISBN-13 | 978-0-323-75498-9 / 9780323754989 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
